ABUJA, NIGERIA — The Federal Government of Nigeria, through the National Health Insurance Authority (NHIA), has officially launched an innovative cost-sharing scheme to support cancer patients with a subsidy of up to ₦400,000 for critical radiotherapy treatments.
Tripod Times reports that The Director-General of the NHIA, Dr. Kelechi Ohiri, announced the medical intervention, highlighting that the initiative is specifically structured to drastically lower the financial barriers hindering accessible cancer care across the country.
Under the newly introduced framework, eligible enrollees and patients will receive a substantial 50% discount on radiotherapy services, with the government covering the balance up to a cap of ₦400,000 per individual.
Medical Experts React
Oncology experts and medical leaders have overwhelmingly praised the development, viewing it as a massive leap forward for oncology practice in West Africa.
Speaking on the operational benefits of the scheme, a consultant radiation oncologist at a prominent federal teaching hospital noted that financial toxicities are often just as dangerous as the malignancies themselves.
“In clinical practice, we regularly witness patients abandon their radiotherapy regimens midway through due to depleted finances,” the oncologist explained on the condition of anonymity.
“When a patient misses their radiation schedule, the tumour can rapidly repopulate, rendering previous sessions ineffective. Providing a ₦400,000 cushion ensures clinical continuity, which directly correlates to higher remission and survival rates.
“Dr. Bernard Audu, Public Relations Officer for the Nigerian Medical Association (NMA) Benue Branch, emphasized the economic relief this brings to broader health systems.
He reiterated that cancer care can place an astronomical financial pressure on families, urging citizens to embrace health insurance.
“Cancer treatment shouldn’t cost a fortune or bankrupt an entire household,” Dr. Audu advised. “With expanding NHIA coverage, enrollees can drastically cut down out-of-pocket strains across chemotherapy, surgeries, and now radiotherapy.
This scheme makes strategic purchasing work directly for the masses.
Advocates Hail Relief for Advanced-Stage Patients
Dr. Adamu Umar, the former President of the Nigerian Cancer Society (NCS), lauded the NHIA for taking a significant, structured step toward equitable care.
He highlighted that radiotherapy is a core, non-negotiable pillar of oncology management, particularly for patients diagnosed at advanced stages of the disease.
“The NHIA’s cost-sharing model is a definitive step in the right direction,” Dr. Umar stated. “Radiotherapy remains out of financial reach for the average Nigerian, and mitigating that strain will prevent families from falling into catastrophic poverty.
However, our next collective goal must be ensuring that an even greater volume of patients can seamlessly access this programme without bureaucratic delays.
Expanding Infrastructure and Partnerships
Beyond direct radiotherapy interventions, the NHIA is actively scaling up collaborations with global pharmaceutical leaders—such as Roche Limited and Pfizer—to introduce similar cost-sharing templates for essential oncology medicines.
Over 200 patients across seven tertiary hospitals nationwide have already begun benefiting from these pooled pharmaceutical arrangements.
This milestone aligns with the Federal Ministry of Health’s overarching “Renewed Hope” health agenda, which targets the delivery of fully functional oncology infrastructure across Nigeria’s geopolitical zones.
The NHIA has urged registered citizens and enrollees battling the disease to leverage the accredited oncology centres to access the subsidized treatment package immediately.
